Investigating the role of a specific gene in Alzheimer's disease using a new mouse model
Inducible overexpression of ABCA7 in astroglia in vivo as a means to study its function in disease pathogenesis
This study is looking at how a gene called ABCA7 might influence the progression of Alzheimer's disease by using special mice that have more of this gene, which could help us understand how it affects a harmful protein linked to the disease, potentially leading to new treatments for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10871231 on NIH RePORTER |
What this research studies
This research focuses on understanding how the ABCA7 gene affects the progression of Alzheimer's disease by creating a new mouse model that overexpresses this gene in astrocytes. The researchers aim to explore the relationship between ABCA7 and the metabolism of amyloid beta, a key factor in Alzheimer's pathology. By using advanced genetic techniques, they hope to gain insights into how ABCA7 influences disease mechanisms, which could lead to new therapeutic strategies. Patients may benefit from the findings as they could inform future treatments for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for late-onset Alzheimer's disease or those with a family history of the condition.
Not a fit: Patients with early-onset Alzheimer's disease or those not genetically predisposed to late-onset Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential treatments for Alzheimer's disease, improving outcomes for patients.
How similar studies have performed: Previous research has shown promise in using genetic models to study Alzheimer's disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lyssenko, Nicholas — Temple Univ of the Commonwealth
- Study coordinator: Lyssenko, Nicholas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.